Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design

Tadej Battelino, Zsolt Bosnyak, Thomas Danne, Bhaswati Mukherjee, Steve Edelman, Valerie Pilorget, Pratik Choudhary, Eric Renard, Richard Bergenstal
2020 Diabetes Therapy  
In the original publication, the timing of baseline CGM assessment was incorrectly stated.
doi:10.1007/s13300-020-00853-7 pmid:32578133 fatcat:j6xg5wcfxvhz5ktdxw57hfswvm